Shanghai Pharmaceuticals industry park design (Shanghai Pharma)

Fast-ex­pand­ing Shang­hai Phar­ma breaks ground on $1.8B biotech park fo­cused on next-gen R&D, an­ti­body pro­duc­tion

One of Chi­na’s biggest bio­phar­ma com­pa­nies is hit­ting the ground run­ning in 2021.

Shang­hai Phar­ma­ceu­ti­cals broke ground Mon­day on a $1.8 bil­lion, 3.2 mil­lion-square-foot in­dus­tri­al park ded­i­cat­ed to R&D work in the bustling field of cell and gene ther­a­pies as well as man­u­fac­tur­ing ther­a­peu­tic an­ti­bod­ies, the firm said.

The mas­sive site is lo­cat­ed in Pudong New Area’s Zhangjiang area and will see con­struc­tion take place in two phas­es — 1.08 mil­lion square feet for the first, and 2.15 mil­lion square feet for the sec­ond. News of the ground­break­ing and ex­pan­sion project was first re­port­ed by SHINE, a dig­i­tal news out­let of the Shang­hai Dai­ly.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Venture & Research Associate

Alexandria Real Estate Equities

San Francisco, CA, USA